Oriens Capital

The three named partners — James Beale, Peter Tinholt, and David Bell (who also serves as CFO) — lead all investment decisions. The firm's website confirms they are the primary deal-makers and portfolio overseers, supported by Investment Manager Ryan Thompson.

Oriens sources opportunities through its partners' deep regional networks in New Zealand, particularly in the Bay of Plenty and broader North Island business communities. By targeting founder-led businesses seeking succession solutions or growth capital, the firm accesses deals that rarely go to broad auction processes.

Oriens Capital is a private equity fund manager. It raises discretionary commingled funds from New Zealand institutions, iwi organizations, community trusts, and individual investors, which it deploys directly into portfolio companies. It does not manage a single family's wealth.

The firm targets control buyouts, succession transitions, management buyouts, and growth equity investments. Stage focus is exclusively on established, revenue-generating private companies in New Zealand, not startups or venture-stage businesses.

Oriens has publicly demonstrated a focus on consumer health manufacturing, as evidenced by its Fund 1 acquisition of About Health. The firm's broader mandate includes manufacturing, health, and business services — all within New Zealand's domestic economy.

Oriens Capital's investor base includes New Zealand institutions, community funds, iwi trusts, charitable organizations, and high-net-worth individuals. The firm pools this domestic capital to deploy into privately held New Zealand businesses.

Oriens does not publicly disclose a co-investment program, and its small team of four suggests a concentrated, direct-investment approach rather than acting as an LP in external funds. The firm's model centers on taking lead or control positions in its own portfolio companies.